Hemgenix has long been given ‘conditional authorisation’. Consequently the ecu Medicines Agency made the decision that the advantages of Hemgenix are higher than its pitfalls, but the company must supply supplemental evidence soon after authorisation.a panel of 3 of clinical specialists with expertise in diagnosing and treating people with hemo